Showing all 5 results

XALKORI 200mg (Crizotinib), 60

7,008.28
ALK-positive or ROS1-positive advanced non-small cell lung cancer.

XALKORI 250mg (Crizotinib), 60

8,737.46
ALK-positive or ROS1-positive advanced non-small cell lung cancer.

ZAVEDOS Oral 10 mg Hartkapseln (idarubicin hydrochloride), 1

240.85
As a second-line drug for the treatment of relapses of acute lymphoblastic leukemia in adults and children.

ZAVEDOS Oral 5 mg Hartkapseln (idarubicin hydrochloride), 3

363.81
As a second-line drug for the treatment of relapses of acute lymphoblastic leukemia in adults and children.